Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeline Continues to Advance with Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results